Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Cough med marketers add icon to label

This article was originally published in The Tan Sheet

Executive Summary

The Consumer Healthcare Products Association says cough medicine marketers have added an educational icon to product labels to alert consumers of the danger of OTC drug abuse and direct them to the Web site StopMedicineAbuse.org, which provides resources for talking to teens about the issue. In addition, CHPA reported that Dr. Drew Pinsky, host of the radio show "Loveline" and star of the VH1 hits "Celebrity Rehab with Dr. Drew" and "Sober House," has joined CHPA's "Five Moms" public health campaign to prevent teen abuse of cough medicine (1"The Tan Sheet" May 14, 2007)

You may also be interested in...



CHPA’s “Five Moms” Uses Web To Lead Latest Public Service Campaign

The Consumer Healthcare Products Association encourages parents to help stop abuse of cough and cold medicines through online networking, the same means by which young people learn to abuse the substances

Organon And Henlius Complete Phase III For Denosumab

Having earlier this year reported positive Phase I data for their partnered denosumab biosimilar candidate, Organon and Shanghai Henlius Biotech have now announced that their HLX14 version has met primary endpoints in a Phase III study.

Taro Agrees $36m Securities Settlement Over US Price-Fixing Claims

Sun’s Taro subsidiary is looking to move forward with an eight-figure settlement deal in the US, after plaintiffs including a firefighters’ pension fund accused the firm of misleading investors via its involvement in generic price fixing, leading to a fall in the price of its securities.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS103449

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel